TP53 mutations are a strong indicator of prognosis, and studies have shown that, in AML, multi-hit mutated TP53 is associated with genomic instability, thrombocytopenia, and a higher blast count, independent of the VAF (Deng et al., 2020). This evidence concerns the gene TP53 and Thrombocytopenia.